DeepNiche

CRISPR in the clinic

11 August 2026

CTX340 hypertension CRISPR trial opens as first-in-human Phase 1/2

NCT07758634 targets enrollment of 69 participants.

source: trial.medpath.com

Get DeepNiche

The full briefing is in the app.

More CRISPR in the clinic clippings